Seguir
Beatriz G. de la Torre
Beatriz G. de la Torre
Dirección de correo verificada de ukzn.ac.za
Título
Citado por
Citado por
Año
Carbon nanotubes with DNA recognition
KA Williams, PTM Veenhuizen, BG de la Torre, R Eritja, C Dekker
Nature 420 (6917), 761-761, 2002
6942002
Green solid-phase peptide synthesis 2. 2-Methyltetrahydrofuran and ethyl acetate for solid-phase peptide synthesis under green conditions
YE Jad, GA Acosta, T Govender, HG Kruger, A El-Faham, BG de la Torre, ...
ACS Sustainable Chemistry & Engineering 4 (12), 6809-6814, 2016
3782016
The pharmaceutical industry in 2018. An analysis of FDA drug approvals from the perspective of molecules
B G de la Torre, F Albericio
Molecules 24 (4), 809, 2019
1742019
The pharmaceutical industry in 2019. An analysis of FDA drug approvals from the perspective of molecules
BG de la Torre, F Albericio
Molecules 25 (3), 745, 2020
1642020
2019 FDA TIDES (peptides and oligonucleotides) harvest
D Al Shaer, O Al Musaimi, F Albericio, BG de la Torre
Pharmaceuticals 13 (3), 40, 2020
148*2020
The pharmaceutical industry in 2018. An analysis of FDA drug approvals from the perspective of molecules
B G de la Torre, F Albericio
Molecules 24 (4), 809, 2019
1452019
Enhanced mucosal immunoglobulin A response and solid protection against foot-and-mouth disease virus challenge induced by a novel dendrimeric peptide
C Cubillos, BG de la Torre, A Jakab, G Clementi, E Borrás, J Bárcena, ...
Journal of virology 82 (14), 7223-7230, 2008
1312008
Peptide Therapeutics 2.0
BG de la Torre, F Albericio
Molecules 25 (10), 2293, 2020
1192020
Activity of Cecropin A-Melittin Hybrid Peptides against Colistin-Resistant Clinical Strains of Acinetobacter baumannii: Molecular Basis for the Differential …
JM Saugar, MJ Rodríguez-Hernández, BG de la Torre, ...
Antimicrobial agents and chemotherapy 50 (4), 1251-1256, 2006
1192006
Synthesis and biological evaluation of a teixobactin analogue
YE Jad, GA Acosta, T Naicker, M Ramtahal, A El-Faham, T Govender, ...
Organic letters 17 (24), 6182-6185, 2015
1102015
Greening Fmoc/t Bu solid-phase peptide synthesis
O Al Musaimi, BG de la Torre, F Albericio
Green chemistry 22 (4), 996-1018, 2020
1022020
Synthesis and binding properties of oligonucleotides carrying nuclear localization sequences
BG de la Torre, F Albericio, E Saison-Behmoaras, A Bachi, R Eritja
Bioconjugate chemistry 10 (6), 1005-1012, 1999
1011999
Stepwise solid-phase synthesis of oligonucleotide-peptide hybrids
BG de la Torre, A Aviñó, G Tarrason, J Piulats, F Albericio, R Eritja
Tetrahedron Letters 35 (17), 2733-2736, 1994
961994
Bactericidal and membrane disruption activities of the eosinophil cationic protein are largely retained in an N-terminal fragment
M Torrent, BG de La Torre, VM Nogués, D Andreu, E Boix
Biochemical Journal 421 (3), 425-434, 2009
922009
Monitoring gene therapy by external imaging of mRNA: Pilot study on murine erythropoietin
J Segura, C Fillat, D Andreu, J Llop, O Millan, BG de la Torre, Z Nikolovski, ...
Therapeutic drug monitoring 29 (5), 612-618, 2007
922007
Peptide synthesis beyond DMF: THF and ACN as excellent and friendlier alternatives
YE Jad, GA Acosta, SN Khattab, BG de la Torre, T Govender, HG Kruger, ...
Organic & biomolecular chemistry 13 (8), 2393-2398, 2015
912015
Short AntiMicrobial Peptides (SAMPs) as a class of extraordinary promising therapeutic agents
S Ramesh, T Govender, HG Kruger, BG de la Torre, F Albericio
Journal of Peptide Science 22 (7), 438-451, 2016
842016
2-Methyltetrahydrofuran and cyclopentyl methyl ether for green solid-phase peptide synthesis
YE Jad, GA Acosta, SN Khattab, BG de la Torre, T Govender, HG Kruger, ...
Amino acids 48, 419-426, 2016
802016
2020 FDA TIDES (peptides and oligonucleotides) harvest
O Al Musaimi, D Al Shaer, F Albericio, BG de la Torre
Pharmaceuticals 14 (2), 145, 2021
792021
Structural dissection of crotalicidin, a rattlesnake venom cathelicidin, retrieves a fragment with antimicrobial and antitumor activity
CB Falcao, C Perez-Peinado, BG de la Torre, X Mayol, ...
Journal of medicinal chemistry 58 (21), 8553-8563, 2015
782015
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–20